IDEXX Surges 1.79 on Record Earnings and Insider Sales as $370M Volume Ranks 330th

On August 13, 2025, IDEXX Laboratories (IDXX) rose 1.79% with a trading volume of $0.37 billion, ranking 330th in market activity. The stock’s performance coincided with insider transactions and strong earnings momentum. Nimrata Hunt, the company’s Executive Vice President, sold 1,200 shares for $787,840 on August 11, as the stock approached its 52-week high of $688.12.

Recent results highlighted IDEXX’s resilience, with Q2 2025 earnings of $3.63 per share surpassing estimates by 17% and revenue reaching $1.11 billion, exceeding forecasts. Analysts at Jefferies raised their price target from $625 to $785, maintaining a Buy rating. The stock’s 58% year-to-date gain reflects sustained demand, supported by robust 10.6% sales growth and 14% EBITDA expansion in the quarter.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The 1-day return was 0.98%, with a total return of 31.52% over 365 days. This indicates the strategy captured some short-term momentum but also reflected market volatility and potential timing risks.